MAchine Learning to Boost the Early Diagnosis of Acute Cardiovascular Conditions

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland

About this trial

The research project aims to develop clinical decision support tools integrating established diagnostic variables and machine learning (ML) models for rapid diagnosis of acute life-threatening cardiovascular conditions in emergency department (ED) patients with chest pain or dyspnea with the ultimate goal of Improved diagnostic accuracy, faster patient management, and reduced medical errors.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

age < 18 years old

patients presenting in cardiogenic shock

chronic terminal kidney failure requiring dialysis

Trial population

Dataset of about 200'000 extensively characterized patients enrolled in randomized controlled trials and observational studies are used

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • Machine learning based development of a diagnostic tool for acute cardiovascular disease

    Other intervention

    MALBEC will be delivered through five integrated work packages (WP) encompassing: (0) platform development and implementation, (1) data pooling, (2) model development, (3) performance comparison, (4) performance validation, and (5) platform plugin

Treatment groups

200,000 Participants
are divided into 1 treatment group
Group A: Patients with acute chest pain and/or acute dyspnoea1 intervention

Trial outcomes

Primary outcomes

1

Developing a clinical decision support tool

Developing and implementing a clinical decision support tool that integrates and visualizes results of established diagnostic variables in a dashboard

Time frame
During whole study duration of 3 years
2

Validate machine learning (ML) models

Derive and validate ML models that integrate cardiac biomarkers with key clinical information and the digital 12-lead ECG to rapidly inform the diagnostic probability for six acute life-threatening cardiovascular conditions in patients presenting with acute chest pain and/or acute dyspnoea to the Emergency Department

Time frame
During whole study duration of 3 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.